Drug Administration - Search News

FDA approves new pain drug Journavx

USA TODAY on MSN · 1h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

CNN on MSN · 12h

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

MassLive · 23m

FDA approves new type of non-addictive painkiller from Boston drug company

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.

Trump administration affirms drug price talks

Hosted on MSN · 2d

Trump's administration aims for 'greater transparency' in drug price negotiations

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following criticism from the pharmaceutical industry for the Biden-era law.

The Plain Dealer Cleveland on M… · 3h

Democrats challenge Trump on drug prices after executive order

More than 50 Democratic U.S. House of Representatives members led by U.S. Rep. Shontel Brown want President Donald Trump’s administration to clarify the effects a new executive order that rescinds a 2022 action issued by his predecessor that created pilot programs aimed at lowering drug costs.

Trump administration affirms drug price talks, but will seek input to ‘improve’ program

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more transparent.

22mon MSN

US drug regulator approves first new type of pain pill in more than 20 years

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

18h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results